Showing results (1591-1600 of 1,763) with videos related to
Sort By:
Pageof 177
Schizophrenia Bulletin Open|August 15, 2024
Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent ActivityKaranvir Gill, Chantal Percival, Meighen Roes, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2026
Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumabErin L MacMillan, Bretta Russell-Schulz, Glaynel Alejo, et al.Current Biology : CB|April 17, 2018
Reconciling Conflicting Phylogenies in the Origin of Sweet Potato and Dispersal to PolynesiaPablo Muñoz-Rodríguez, Tom Carruthers, John R I Wood, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
Translation initiation factor eIF1.2 promotes <i>Toxoplasma</i> stage conversion by regulating levels of key differentiation factorsFengrong Wang, Michael J Holmes, Hea Jin Hong, et al.Neuro-Oncology|April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trialCatherine Hanna, Kathreena M Kurian, Karin Williams, et al.Scientific Reports|August 31, 2021
The human type 2 diabetes-specific visceral adipose tissue proteome and transcriptome in obesityNicholas J Carruthers, Clarissa Strieder-Barboza, Joseph A Caruso, et al.The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.Medical Teacher|April 1, 2010
Undergraduate medical education in the Gulf Cooperation Council: a multi-countries study (Part 2)H Hamdy, A W Telmesani, N Al Wardy, et al.European Journal of Haematology|December 23, 2016
IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case seriesMollie N Carruthers, Sujin Park, Graham W Slack, et al.The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.Pageof 177